Trial intelligence / Profile preview

Ketamine for emergence agitation after nasal surgery

NCT05313659Phase 2Completed

Sponsor
Royal Medical Services
Start
May 2022
Primary completion
Oct 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ketamine in Emergence agitation (EA), sponsored by Royal Medical Services. Started May 2022; status: completed.

02

Drugs

ketamine
03

Conditions

Emergence agitation (EA)

Beyond the preview

Go deeper on NCT05313659.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05313659.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call